GPC3-CAR-T cells
/ Peking University
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 25, 2022
Novel GPC3 CAR-T Cell Therapy for Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: Peking University
CAR T-Cell Therapy • New P1 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor • GPC3
1 to 1
Of
1
Go to page
1